Thirty-four patients with chronic pyoderma have been examined. Fifteen of these have been treated with mielopid (18 mg per course). Immunologic and clinical examinations carried out in 3-10 months after therapy have demonstrated a wide-spectrum immunostimulating action of the new drug.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
patients chronic
8
[effectiveness soviet
4
soviet immunomodulator
4
immunomodulator mielopid
4
mielopid combined
4
combined treatment
4
treatment patients
4
chronic pyoderma]
4
pyoderma] thirty-four
4
thirty-four patients
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!